Hampstead

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC	Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm	Recruiting	Phase 3	2026-09-30	NCT06765109
A Long-Term Study of Navenibart in Participants With Hereditary Angioedema	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hereditary Complement Deficiency Diseases, Hypersensitivity, Immediate, Primary Immunodeficiency Diseases, Skin and Connective Tissue Diseases, angioedema, cardiovascular disorder, hereditary angioedema, hereditary disease, immune system disorder, inborn error of immunity, skin disorder, skin vascular disease, urticaria, vascular disorder	Enrolling by invitation	Phase 3	2026-07-30	NCT07204938
An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)	Nutritional and Metabolic Diseases, amyloidosis, metabolic disease, proteostasis deficiencies	Enrolling by invitation	Phase 3	2026-04-17	NCT05667493

Clinical trials